{"id":"https://openalex.org/W4416670366","doi":"https://doi.org/10.1158/1078-0432.30710387","title":"Supplementary Table S4 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor\u2013Induced Growth Suppression","display_name":"Supplementary Table S4 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor\u2013Induced Growth Suppression","publication_year":2025,"publication_date":"2025-11-25","ids":{"openalex":"https://openalex.org/W4416670366","doi":"https://doi.org/10.1158/1078-0432.30710387"},"language":null,"primary_location":{"id":"doi:10.1158/1078-0432.30710387","doi":"https://doi.org/10.1158/1078-0432.30710387","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30710387","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.30710387","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086238346","display_name":"Chuandong Geng","orcid":"https://orcid.org/0000-0002-1487-2411","observed_orcids":["https://orcid.org/0000-0002-1487-2411"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chuandong Geng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1487-2411","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085564412","display_name":"Man-Chao Zhang","orcid":"https://orcid.org/0000-0002-8154-8136","observed_orcids":["https://orcid.org/0000-0002-8154-8136"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Man-Chao Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8154-8136","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077756892","display_name":"Ganiraju C. Manyam","orcid":"https://orcid.org/0000-0001-6006-8961","observed_orcids":["https://orcid.org/0000-0001-6006-8961"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ganiraju C. Manyam","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6006-8961","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040696818","display_name":"Jody V. Vykoukal","orcid":"https://orcid.org/0000-0001-7797-627X","observed_orcids":["https://orcid.org/0000-0001-7797-627X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jody V. Vykoukal","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7797-627X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072417435","display_name":"Johannes Francois Fahrmann","orcid":"https://orcid.org/0000-0001-5088-0198","observed_orcids":["https://orcid.org/0000-0001-5088-0198"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johannes F. Fahrmann","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5088-0198","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110419976","display_name":"Shan Peng","orcid":"https://orcid.org/0000-0003-1391-4453","observed_orcids":["https://orcid.org/0000-0003-1391-4453"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shan Peng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1391-4453","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008103342","display_name":"Cheng Wu","orcid":"https://orcid.org/0000-0003-2707-6163","observed_orcids":["https://orcid.org/0000-0003-2707-6163"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cheng Wu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2707-6163","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010774465","display_name":"Sanghee Park","orcid":"https://orcid.org/0009-0002-2009-1790","observed_orcids":["https://orcid.org/0009-0002-2009-1790"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sanghee Park","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-2009-1790","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009269658","display_name":"Shakuntala Kondraganti","orcid":"https://orcid.org/0009-0000-2044-9989","observed_orcids":["https://orcid.org/0009-0000-2044-9989"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shakuntala Kondraganti","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-2044-9989","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002336006","display_name":"Daoqi Wang","orcid":"https://orcid.org/0000-0002-6098-9477","observed_orcids":["https://orcid.org/0000-0002-6098-9477"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daoqi Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6098-9477","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058816521","display_name":"Brian D. Robinson","orcid":"https://orcid.org/0000-0001-5374-890X","observed_orcids":["https://orcid.org/0000-0001-5374-890X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian D. Robinson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5374-890X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071763026","display_name":"Massimo F. Loda","orcid":"https://orcid.org/0000-0001-9674-8379","observed_orcids":["https://orcid.org/0000-0001-9674-8379"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Massimo Loda","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9674-8379","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031824245","display_name":"Christopher E. Barbieri","orcid":"https://orcid.org/0000-0002-0381-1947","observed_orcids":["https://orcid.org/0000-0002-0381-1947"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher E. Barbieri","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0381-1947","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068368047","display_name":"Timothy Anthony Yap","orcid":"https://orcid.org/0000-0002-2154-3309","observed_orcids":["https://orcid.org/0000-0002-2154-3309"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy A. Yap","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2154-3309","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062740919","display_name":"Paul Gettys Corn","orcid":"https://orcid.org/0000-0002-4106-6335","observed_orcids":["https://orcid.org/0000-0002-4106-6335"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul G. Corn","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4106-6335","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040156444","display_name":"Samir Hanash","orcid":"https://orcid.org/0000-0002-4210-1593","observed_orcids":["https://orcid.org/0000-0002-4210-1593"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samir Hanash","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4210-1593","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012234751","display_name":"Bradley McIntosh Broom","orcid":"https://orcid.org/0000-0002-0915-3164","observed_orcids":["https://orcid.org/0000-0002-0915-3164"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bradley M. Broom","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0915-3164","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022629958","display_name":"Patrick Glen Pilie","orcid":"https://orcid.org/0000-0001-8759-0020","observed_orcids":["https://orcid.org/0000-0001-8759-0020","https://orcid.org/0000-0002-7867-2611"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick G. Pili\u00e9","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8759-0020","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5042000405","display_name":"Timothy C. Thompson","orcid":"https://orcid.org/0000-0003-1424-3831","observed_orcids":["https://orcid.org/0000-0003-1424-3831"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy C. Thompson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1424-3831","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.6875,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.6875,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.23680000007152557,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.016699999570846558,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/spop-mutations","display_name":"SPOP mutations","score":0.8679999709129333},{"id":"https://openalex.org/keywords/sting1-signaling","display_name":"STING1 signaling","score":0.996999979019165},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9959999918937683},{"id":"https://openalex.org/keywords/growth-inhibition","display_name":"growth inhibition","score":0.6399999856948853},{"id":"https://openalex.org/keywords/therapeutic-vulnerabilities","display_name":"therapeutic vulnerabilities","score":0.6420000195503235},{"id":"https://openalex.org/keywords/rt-qpcr-primers","display_name":"qRT-PCR primers","score":0.8870000243186951}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6904000043869019},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.6014000177383423},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5878999829292297},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4894999861717224},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.4551999866962433},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39489999413490295},{"id":"https://openalex.org/C98108389","wikidata":"https://www.wikidata.org/wiki/Q412563","display_name":"CRISPR","level":3,"score":0.391400009393692},{"id":"https://openalex.org/C2779820595","wikidata":"https://www.wikidata.org/wiki/Q798505","display_name":"Listing (finance)","level":2,"score":0.37229999899864197},{"id":"https://openalex.org/C205003668","wikidata":"https://www.wikidata.org/wiki/Q17113442","display_name":"Chromoplexy","level":5,"score":0.3357999920845032},{"id":"https://openalex.org/C116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","level":2,"score":0.33180001378059387},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.3208000063896179},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3165000081062317},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3124000132083893},{"id":"https://openalex.org/C129312508","wikidata":"https://www.wikidata.org/wiki/Q133686","display_name":"Oligonucleotide","level":3,"score":0.3102000057697296},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.2696000039577484},{"id":"https://openalex.org/C2778384578","wikidata":"https://www.wikidata.org/wiki/Q16930687","display_name":"Therapeutic approach","level":3,"score":0.25690001249313354}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.30710387","doi":"https://doi.org/10.1158/1078-0432.30710387","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30710387","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30710387","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Supplementary_Table_S4_from_SPOP_Mutations_Target_STING1_Signaling_in_Prostate_Cancer_and_Create_Therapeutic_Vulnerabilities_to_PARP_Inhibitor_Induced_Growth_Suppression/30710387","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.30710387","doi":"https://doi.org/10.1158/1078-0432.30710387","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30710387","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Supplementary":[0],"Table":[1],"S4.":[2],"Complete":[3],"listing":[4],"and":[5],"details":[6],"of":[7],"oligonucleotide":[8],"primers":[9],"used":[10],"for":[11],"RT-qPCR":[12],"analysis.":[13]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2025-11-25T00:00:00"}